Assessment of hypertension control and factors associated with the control among hypertensive patients attending at Zewditu Memorial Hospital: a cross sectional study

BMC Research Notes

卷:12

Boressa Adugna Horsa¹  Yewondwossen Tadesse²  Ephrem Engidawork³ 

[1] Department of Clinical Pharmacy, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar;

[2] Department of Internal Medicine, School of Medicine, College of Health Sciences, Addis Ababa University;

[3] Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University;

关键词: Hypertension;    Antihypertensive treatment;    Blood pressure control;    Ethiopia;   

DOI  :  10.1186/s13104-019-4173-8

来源: DOAJ

【 摘 要 】

Abstract Objective This study was conducted to assess hypertension control and factors associated with it among hypertensive patients on treatment at Zewditu Memorial Hospital. Results A total of 225 patients were included in the study, of which 55.6% of patients were females. The mean age of the patients was 55.2 years and half of them had a family history of hypertension. About 29% of patients had comorbidities. Angiotensin-converting enzyme inhibitors (ACEIs), calcium channel blockers (CCBs) and beta-blockers (BBs) were the most frequently prescribed medications. Majority of (83.1%) the patients received combination therapy. The most frequent two and three drugs class combination were ACEI + BB and ACEIs + CCB + BB, respectively. Drug treatment was modified for 22.2% of patients and blood pressure (BP) was controlled in 26.2% of patients. Older age was associated with good BP control (AOR 2.58, CI 1.27–5.24), while treatment modification was associated with poor BP control (AOR 0.21, CI 0.07–0.65). The findings indicate that BP control was low and factors like middle age and treatment modification contributed to the low BP control. It is recommended that the physicians should be adherent to current guidelines regarding the selection of appropriate antihypertensive medications so as to achieve target BP goals.

【 授权许可】

Unknown